Researchers begin a study of two potential Ebola treatments in eastern Congo as the outbreak continues to grow. Multiple outlets report that the trial starts on Thursday and is intended to test therapies that could help address the escalating situation. The work focuses on the Ebola virus strain linked to the outbreak, described as Bundibugyo, which is noted as less common than other Ebola-causing virus types. Reporting from the World Health Organization indicates that the study reaches a key milestone as the first participant is enrolled. The sources describe the trial as highly anticipated and tied to an effort to identify effective options for managing the outbreak. While the articles provide limited details on study design or the specific treatment names, they agree that researchers are launching the trial during the worsening phase of the outbreak and that WHO enrollment progress is underway. Overall, the coverage emphasizes the trial’s commencement, the focus on Bundibugyo Ebola, and the enrollment of an initial participant by WHO as researchers move forward with evaluating potential treatments.